Indication

Chlamydia trachomatis pelvic inflammatory disease

*Chlamydia trachomatis* pelvic inflammatory disease is an acute or subacute infectious and inflammatory syndrome affecting the upper female reproductive tract, resulting from the ascending spread of the obligate intracellular bacterium *Chlamydia trachomatis* from the endocervix and vagina. Read more about Chlamydia trachomatis pelvic inflammatory disease

68 drugs 52 manufacturers

Advertisement

Drugs that treat it

Common Chlamydia trachomatis pelvic inflammatory disease therapies.

Showing 37–45 of 68 drugs

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
Lannett Company

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
Major Pharamceuticals

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
AVKARE

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
QUALITY CARE

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
AVPAK

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
TARO PHARM USA

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
PHARMPAK

AZITHROMYCIN

MACROLIDE ANTIBIOTICS·PHARYNGITIS DUE TO STREPTOCOCCUS PYOGENES·+27
A-S MEDICATION
Filter & compare in the drug finder →Opens the drug finder with Chlamydia trachomatis pelvic inflammatory disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chlamydia trachomatis pelvic inflammatory disease.

*Chlamydia trachomatis* pelvic inflammatory disease is an acute or subacute infectious and inflammatory syndrome affecting the upper female reproductive tract, resulting from the ascending spread of the obligate intracellular bacterium *Chlamydia trachomatis* from the endocervix and vagina.

It manifests across a spectrum of pathology, including endometritis, salpingitis, tubo-ovarian abscess, and pelvic peritonitis, predominantly occurring in sexually active women and adolescent females.

Clinical presentations vary from indolent or subclinical inflammation to overt lower abdominal pain, cervical motion tenderness, uterine or adnexal tenderness, and abnormal vaginal or cervical discharge.

Left untreated, the host inflammatory response can cause irreversible structural damage to the fallopian tubes, leading to serious long-term sequelae such as tubal-factor infertility, ectopic pregnancy, and chronic pelvic pain.

Personalize your experience

Follow Chlamydia trachomatis pelvic inflammatory disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it